These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11840823)

  • 21. Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability.
    Hardisson D; Moreno-Bueno G; Sánchez L; Sarrió D; Suárez A; Calero F; Palacios J
    Mod Pathol; 2003 Nov; 16(11):1148-58. PubMed ID: 14614055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
    Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
    J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetic abnormalities and microsatellite instability in endometrial adenocarcinoma.
    Sirchia SM; Pariani S; Rossella F; Garagiola I; De Andreis C; Bulfamante G; Zannoni E; Radaelli U; Simoni G
    Cancer Genet Cytogenet; 1997 Apr; 94(2):113-9. PubMed ID: 9109939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA ploidy and S-phase fraction analyses of hyperplastic, atypical and cancerous endometrium using flow cytometry from paraffin-embedded tissues.
    Pervez S; Hitchcock A; Sinton TM; Mani A; Smith JL
    Pathol Res Pract; 2002; 198(1):13-7. PubMed ID: 11866205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Amplification and expression of HER-2 oncogene in precancerous stages and cancers of the endometrium].
    Czerwenka KF; Heuss F; Zeillinger R; Hosmann JW; Wagner T; Manavi M; Jelincic D; Lu Y; Kubista E
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():287-8. PubMed ID: 7906978
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression.
    Feng YZ; Shiozawa T; Miyamoto T; Kashima H; Kurai M; Suzuki A; Konishi I
    Clin Cancer Res; 2005 Sep; 11(17):6133-8. PubMed ID: 16144912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma.
    Henderson GS; Brown KA; Perkins SL; Abbott TM; Clayton F
    Mod Pathol; 1996 Apr; 9(4):430-8. PubMed ID: 8729985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population.
    Kanaya T; Kyo S; Sakaguchi J; Maida Y; Nakamura M; Takakura M; Hashimoto M; Mizumoto Y; Inoue M
    Am J Clin Pathol; 2005 Jul; 124(1):89-96. PubMed ID: 15923161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microsatellite instability (MSI) analysis in patients with endometrial cancer.
    Dec G; Romanowicz-Makowska H; Smolarz B; Kulig A
    Pol J Pathol; 2005; 56(1):15-9. PubMed ID: 15921009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A comparative morphometric and DNA content study of endometrial hyperplasia and adenocarcinoma].
    Zhou XR; Du XG
    Zhonghua Fu Chan Ke Za Zhi; 1992 Sep; 27(5):278-80, 316. PubMed ID: 1298588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations.
    Semczuk A; Lorenc A; Putowski L; Futyma K; Bryk J; Miotla P; Bartnik E
    Oncol Rep; 2006 Nov; 16(5):1041-5. PubMed ID: 17016590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
    Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
    Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium.
    Rasty G; Murray R; Lu L; Kubilis P; Benrubi G; Masood S
    Ann Clin Lab Sci; 1998; 28(3):138-43. PubMed ID: 9646853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA replication error in endometrial carcinoma and complex atypical endometrial hyperplasia.
    Ohwada M; Suzuki M; Kashiwagi H; Konishi F; Sato I
    Cancer Genet Cytogenet; 1999 Oct; 114(2):130-5. PubMed ID: 10549270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent microsatellite instability in synchronous ovarian and endometrial adenocarcinoma and its usefulness for differential diagnosis.
    Kaneki E; Oda Y; Ohishi Y; Tamiya S; Oda S; Hirakawa T; Nakano H; Tsuneyoshi M
    Hum Pathol; 2004 Dec; 35(12):1484-93. PubMed ID: 15619207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
    Zhou XH; Teng XD; Song WY; Wu YJ
    Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic progression in sporadic endometrial and gastrointestinal cancers with high microsatellite instability.
    Furlan D; Casati B; Cerutti R; Facco C; Terracciano L; Capella C; Chiaravalli AM
    J Pathol; 2002 Aug; 197(5):603-9. PubMed ID: 12210079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium.
    Tanos V; Ariel I; Prus D; De-Groot N; Hochberg A
    Int J Gynecol Cancer; 2004; 14(3):521-5. PubMed ID: 15228427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of telomerase genes as potential marker of neoplastic changes.
    Mazurek U; Witek A; Olejek A; Paul M; Skałba P; Wilczok T
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():183-4. PubMed ID: 11820598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.